Is risk-reducing endocrine therapy done with tamoxifen?

Tamoxifen is a medicine that changes how oestrogen signals are received in some breast cells. In risk reduction, it is considered for people whose future breast cancer risk is high enough that preventive medicine may be useful, even when they do not have breast cancer currently. It is not suitable for everyone, and the decision depends on age, health history, menstrual status, medicines, and personal preferences.

The possible downsides include menopausal-type symptoms and uncommon but serious problems involving blood clots or the womb. A clinician will review those concerns alongside your risk factors and discuss other approaches, including closer screening or risk-reducing surgery when relevant.

Give the prescribing team a complete list of medicines, supplements, previous blood clots, bleeding problems, liver conditions, and reproductive plans. Ask how tamoxifen would fit with contraception, pregnancy planning, and any procedure you may need. Take it exactly as prescribed and do not stop it suddenly without discussing the reason.

Keep any planned breast assessment and report troublesome symptoms early. The choice is shared: a risk estimate, expected benefits, side effects, and your comfort with daily treatment all belong in the conversation.

Seek urgent help for sudden chest pain, breathlessness, coughing blood, one-sided leg swelling or pain, sudden weakness, or difficulty speaking. Contact your clinician promptly about unexpected vaginal bleeding, pelvic pain, or vision changes. These symptoms can have different causes, but they should not be ignored while taking tamoxifen.

What makes tamoxifen appropriate for my risk profile? How long would I take it, and how would we monitor side effects? Which symptoms require urgent help? Are there medicines or supplements I should avoid?